Follow


Submissions from 2024

Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies, Bruno Bastos

First 30 Days Wound-Related Complications in Young Smokers Following Primary Achilles Repair, Thomas SanGiovanni, Cary Chapman, and Christopher Hodgkins

Impact of TP53, RB1, and PTEN Mutations on Overall Survival in Metastatic Prostate Cancer: A Multi-center Study Via the Guardian Research Network., Mohammad Ganiyani, Pushan Prabhakar, Atulya Khosla, Shreyas Bellur, Arjun Avudaiappan, Bruno Bastos, and Rohan Garje

Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436), Bruno Bastos

Submissions from 2023

Characterization of Physical Function and Cancer-Related Physical Impairments in Hispanic Women With Breast Cancer: A Descriptive Study, Adrian Cristian, Muni Rubens, Grace Wang, and Jane Mendez

A Multi-Institutional Phase II Trial of Ablative 5-Fraction Stereotactic MR-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer, Kathryn Mittauer and Michael Chuong

Radiation induced taste changes in head and neck cancer - differential impact of treatment factors, Tiffany Nong, Tammy Medrano, Muni Rubens, Adeel Kaiser, and Noah Kalman

Ablative 5-fraction CT- versus MR-guided pancreatic SBRT: dosimetric effects of interfraction anatomic change, Michael Chuong, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Diane Alvarez, Nema Bassiri-Gharb, Alonso Gutierrez, James McCulloch, Kathryn Mittauer, Nicole McAllister, Ashley Fellows, Amy Rzepczynski, and Will Deere

A comparative evaluation of different radiosurgery management strategies for large brain metastases: What is the optimal treatment paradigm?, Tugce Kutuk, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Anshul Saxena, Alonso La Rosa de los Rios, Martin Tom, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Mukesh Roy

Advancing Beyond the Hippocampus to Improve Cognition for Patients with Brain Metastases: An Initial Report of a Phase 2 Trial Examining Memory-Avoidance Whole Brain Radiotherapy, Rupesh Kotecha

Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery (SSRS): Phase 1 Proof-of-Concept Interim Analysis, Alonso La Rosa de los Rios, Surya Chundru, Martin Tom, Tugce Kutuk, D Jay Wieczorek, Muni Rubens, Ranjini Tolakanahalli, Michael McDermott, Matthew Hall, Alonso Gutierrez, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

Integration of an APP-based Neurocognitive Evaluation Program into Stereotactic Radiosurgery Practice: Outcomes and Patient Survey Analysis from a Prospective Observational Study, Tugce Kutuk, Cecilia Lee, Yazmin Odia, Alonso La Rosa de los Rios, Matthew Hall, Haley Appel, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

"Multi-institutional Experience of Definitive Proton Therapy for Osteosarcoma Acute Toxicities and Outcomes", Keitrina Mair, Katherine Von Werne, Noah Kalman, Michael Chuong, Matthew Hall, and Robert Press

Outcomes of MR-guided Stereotactic Body Radiotherapy (MRgSBRT) for adrenal metastases: A multi-institutional pooled analysis, Rupesh Kotecha and Tugce Kutuk

Patterns of locoregional failure after ablative 5-fraction stereotactic MR-guided on-table adaptive radiation therapy for pancreatic cancer, Michael Chuong, Nicole McAllister, Surya Chundru, Robert Herrera, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Kathryn Mittauer, Diane Alvarez, James McCulloch, Nema Bassiri-Gharb, Alonso Gutierrez, Nicolas Carvallo, and Jason Extein

Phase II Trial of Stereotactic MR-guided On-table Adaptive Radiation Therapy for Borderline or Locally Advanced Pacreatic Cancer: Updated Safety & Efficacy Outcomes, Michael Chuong and Kathryn Mittauer

Stereotactic Radiosurgery for Small Intact Brain Metastasis: A Comparative Evaluation Between 3 Single Fraction Prescription Doses, Sreenija Yarlagadda, Tugce Kutuk, Anshul Saxena, Mukesh Roy, Ranjini Tolakanahalli, Haley Appel, Alonso La Rosa de los Rios, Martin Tom, Matthew Hall, D Jay Wieczorek, Michael McDermott, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha

Surgically Targeted Radiation Therapy (STaRT) for brain metastases: Initial Experience from a Prospective Multi-institutional Registry, Rupesh Kotecha and Michael McDermott

Treatment of Thymoma and Thymic Carcinoma with Proton Beam Therapy: Long-term Outcomes from the Proton Collaborative Group Registry, Michael Chuong

BPI23-011: Real-World Study of First-Line Treatment Patterns in HR+/HER2– Metastatic Breast Cancer (MBC) at a Tertiary Care Cancer Institute, Yolcar Chamorro, Manmeet Ahluwalia, Muni Rubens, Reshma Mahtani, and Ana Sandoval Leon

Predicting Risk of Distant Brain Failure with Radiosurgery and Systemic Therapy in a Diverse NSCLC Brain Metastasis Population, Sreenija Yarlagadda, Tugce Kutuk, Anshul Saxena PhD, Ranjini Tolakanahalli, Haley Appel, Alonso La Rosa de los Rios, Matthew Hall, D Jay Wieczorek, Cecilia Lee, Michael McDermott, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Mukesh Roy

A Multicenter Study of Low-Intensity Focused Ultrasound with Systemic Microbubble Oscillators for Blood-Brain Barrier Disruption for Liquid Biopsy in Glioblastoma (LIBERATE), Manmeet Ahluwalia, Michael McDermott, Ahmad Ozair, and Atulya Khosla

A Randomized Phase 2b Study of Surviving Vaccine Survaxm Plus Adjuvant Temozolomide For Newly-Diagnosed Glioblastoma (SURVIVE), Manmeet Ahluwalia, Yazmin Odia, Ahmad Ozair, and Atulya Khosla

A Randomized Study of Low-Intensity Focused Ultrasound for Blood-Brain Barrier Disruption for Brain Metastasis from Non-Small Cell Lung Cancer (LIMITLESS), Manmeet Ahluwalia, Michael McDermott, Ahmad Ozair, and Atulya Khosla

PDF

Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial, Manmeet Ahluwalia, Ahmad Ozair, and Atulya Khosla